Assessment of the long-term transcriptional activity of a 550-bp-long human β-actin promoter region

Plasmid

Volumn 68, Issue 3, 2012, Pages 195-200

  Damdindorj, Lkhagvasuren ^a   Karnan, Sivasundaram ^a   Ota, Akinobu ^a   Takahashi, Miyuki ^a   Konishi, Yuko ^a   Hossain, Ekhtear ^a   Hosokawa, Yoshitaka ^a   Konishi, Hiroyuki ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

actin; ACTB; Long term activity; Promoter

Indexed keywords

BETA ACTIN; ELONGATION FACTOR 1ALPHA; ENHANCED GREEN FLUORESCENT PROTEIN; THYMIDINE KINASE;

ARTICLE; BETA ACTIN GENE; CONTROLLED STUDY; CYTOMEGALOVIRUS; ELONGATION FACTOR 1 ALPHA GENE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GENE; GENE CONSTRUCT; GENE EXPRESSION SYSTEM; GENE VECTOR; GENETIC STABILITY; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; PLASMID; PROMOTER REGION; SIGNAL TRANSDUCTION; SOMATIC CELL; THYMIDINE KINASE GENE; TRANSCRIPTION INITIATION;

ACTINS; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HCT116 CELLS; HUMANS; PLASMIDS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

CYTOMEGALOVIRUS; SIMPLEXVIRUS;

EID: 84865650793     PISSN: 0147619X     EISSN: 10959890     Source Type: Journal    
DOI: 10.1016/j.plasmid.2012.07.003     Document Type: Article

References (25)

1. Bronson S.K., Plaehn E.G., Kluckman K.D., Hagaman J.R., Maeda N., Smithies O. Single-copy transgenic mice with chosen-site integration. Proc. Natl. Acad. Sci. USA 1996, 93:9067-9072.
2. Chan K.K., Wu S.M., Nissom P.M., Oh S.K., Choo A.B. Generation of high-level stable transgene expressing human embryonic stem cell lines using Chinese hamster elongation factor-1 alpha promoter system. Stem Cells Dev. 2008, 17:825-836.
3. Danilition S.L., Frederickson R.M., Taylor C.Y., Miyamoto N.G. Transcription factor binding and spacing constraints in the human beta-actin proximal promoter. Nucleic Acids Res. 1991, 19:6913-6922.
4. Frederickson R.M., Micheau M.R., Iwamoto A., Miyamoto N.G. 5' flanking and first intron sequences of the human beta-actin gene required for efficient promoter activity. Nucleic Acids Res. 1989, 17:253-270.
5. Garrels J.I., Gibson W. Identification and characterization of multiple forms of actin. Cell 1976, 9:793-805.
6. Gill D.R., Smyth S.E., Goddard C.A., Pringle I.A., Higgins C.F., Colledge W.H., Hyde S.C. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gene Ther. 2001, 8:1539-1546.
7. Gopalkrishnan R.V., Christiansen K.A., Goldstein N.I., DePinho R.A., Fisher P.B. Use of the human EF-1alpha promoter for expression can significantly increase success in establishing stable cell lines with consistent expression: a study using the tetracycline-inducible system in human cancer cells. Nucleic Acids Res. 1999, 27:4775-4782.
8. Gunning P., Leavitt J., Muscat G., Ng S.Y., Kedes L. A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA 1987, 84:4831-4835.
9. Kang J., Wither J., Hozumi N. Long-term expression of a T-cell receptor beta-chain gene in mice reconstituted with retrovirus-infected hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 1990, 87:9803-9807.
10. Kawamoto T., Makino K., Orita S., Nakata A., Kakunaga T. DNA bending and binding factors of the human beta-actin promoter. Nucleic Acids Res. 1989, 17:523-537.
11. Kim D.W., Harada T., Saito I., Miyamura T. An efficient expression vector for stable expression in human liver cells. Gene 1993, 134:307-308.
12. Kosuga M., Enosawa S., Li X.K., Suzuki S., Matsuo N., Yamada M., Roy-Chowdhury J., Koiwai O., Okuyama T. Strong, long-term transgene expression in rat liver using chicken beta-actin promoter associated with cytomegalovirus immediate-early enhancer (CAG promoter). Cell Transplant. 2000, 9:675-680.
13. Li M., Hantzopoulos P.A., Banerjee D., Zhao S.C., Schweitzer B.I., Gilboa E., Bertino J.R. Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors. Hum. Gene Ther. 1992, 3:381-390.
14. Liew C.G., Draper J.S., Walsh J., Moore H., Andrews P.W. Transient and stable transgene expression in human embryonic stem cells. Stem cells 2007, 25:1521-1528.
15. Mao J., Qiao X., Luo H., Wu J. Transgenic drak2 overexpression in mice leads to increased T cell apoptosis and compromised memory T cell development. J. Biol. Chem. 2006, 281:12587-12595.
16. Moshier J.A., Dosescu J., Skunca M., Luk G.D. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Cancer Res. 1993, 53:2618-2622.
17. Najjar S.M., Lewis R.E. Persistent expression of foreign genes in cultured hepatocytes: expression vectors. Gene 1999, 230:41-45.
18. Nakagawa K., Yajima K., Yamashita K., Ikenaka Y., Yokota S., Kakutani T., Kawaharada H., Watanabe K. Constitutive high-level production of human lymphotoxin by CHO-K1 cells transformed with the human lymphotoxin gene controlled by a human beta-actin promoter. Agric. Biol. Chem. 1991, 55:501-508.
19. Ng S.Y., Gunning P., Liu S.H., Leavitt J., Kedes L. Regulation of the human beta-actin promoter by upstream and intron domains. Nucleic Acids Res. 1989, 17:601-615.
20. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108:193-199.
21. Sugiyama H., Niwa H., Makino K., Kakunaga T. Strong transcriptional promoter in the 5' upstream region of the human beta-actin gene. Gene 1988, 65:135-139.
22. Teschendorf C., Warrington K.H., Siemann D.W., Muzyczka N. Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus. Anticancer Res. 2002, 22:3325-3330.
23. Tsakiridis A., Tzouanacou E., Rahman A., Colby D., Axton R., Chambers I., Wilson V., Forrester L., Brickman J.M. Expression-independent gene trap vectors for random and targeted mutagenesis in embryonic stem cells. Nucleic Acids Res. 2009, 37:e129.
24. Van Molle W., Van Roy M., Van Bogaert T., Dejager L., Van Lint P., Vanlaere I., Sekikawa K., Kollias G., Libert C. Protection of zinc against tumor necrosis factor induced lethal inflammation depends on heat shock protein 70 and allows safe antitumor therapy. Cancer Res. 2007, 67:7301-7307.
25. Zeng X., Chen J., Sanchez J.F., Coggiano M., Dillon-Carter O., Petersen J., Freed W.J. Stable expression of hrGFP by mouse embryonic stem cells: promoter activity in the undifferentiated state and during dopaminergic neural differentiation. Stem cells 2003, 21:647-653.